Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM ... domestic CGM market in the US to reach $7.8 billion in 2025 and more than $10 billion ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

Now, we can confirm that rival Samsung is proving many wrongs by giving insights into its holy grail feature which entails a non-invasive glucose monitor. So far, no other tech giant has been able to ...

Enabling enterprises to disrupt, transform and innovate using Google Cloud ...